ArticlePLoS medicine2017

Biomarker-Defined Subsets of Common Diseases: Policy and Economic Implications of Orphan Drug Act Coverage.

Aaron S Kesselheim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.